Allergic Conjunctivitis

• FDA label_change · 2025-10-22
  FDA Approved: VISINE ALLERGY EYE RELIEF MULTI-ACTION — Supplemental Application (Kenvue Brands LLC)

  FDA approved a supplemental application to update the labeling for VISINE ALLERGY EYE RELIEF MULTI-ACTION, a combination eye drop containing…

• FDA label_change · 2020-09-30
  FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

  FDA approved a supplemental application to expand Pataday to once-daily dosing for allergic conjunctivitis.

• FDA label_change · 2020-06-09
  FDA Approved: LASTACAFT — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for LASTACAFT (alcaftadine) from Allergan, resulting in changes to the labeling.

• FDA label_change · 2015-11-27
  FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

  FDA approved a supplemental application for Pataday Once Daily Relief (olopatadine hydrochloride) from Alcon Laboratories, Inc. to update th…

• FDA label_change · 2015-10-08
  FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

  FDA approved a supplemental application for Pataday Once Daily Relief to update the labeling for olopatadine hydrochloride, expanding its la…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2015-09-16
  FDA Approved: ZADITOR — Supplemental Application (Alcon Laboratories, Inc.)

  The FDA approved a supplemental application for Zaditor (ketotifen fumarate) submitted by Alcon Laboratories, Inc.

• FDA label_change · 2014-08-12
  FDA Approved: LASTACAFT — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for LASTACAFT (alcaftadine) by Allergan, Inc., resulting in a labeling change following the suppleme…

• FDA label_change · 2007-06-08
  FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

  The FDA approved a supplemental application for PATADAY ONCE DAILY RELIEF (olopatadine hydrochloride) to support a once-daily dosing label f…

• FDA label_change · 2007-04-18
  FDA Approved: EYE ITCH RELIEF — Supplemental Application (Target Corporation)

  FDA approves a supplemental application for Eye Itch Relief containing ketotifen fumarate, updating the product’s labeling.